Dante Romagnoli
- Hepatology top 1%
- Liver Disease and Transplantation 6
- Hepatitis C virus research 4
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Liver Diseases and Immunity 3
-
- Diet, Metabolism, and Disease 5
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 19
-
- Cardiovascular Disease and Adiposity 2
- Lipid metabolism and disorders 2
- Co-authors
- Amedeo LonardoStefano BallestriFabio NascimbeniEnrica BaldelliGiovanni TargherAlessandra MarrazzoGiovanni GuaraldiStefano Zona
- Journals
- Advances in Therapy (2 papers)World Journal of Gastroenterology (2 papers)Digestive and Liver Disease (2 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Dante Romagnoli
24 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 616
- Endocrinology, Diabetes and Metabolism 820
- Epidemiology 1.6k
- Pathology and Forensic Medicine 308
- Cardiology and Cardiovascular Medicine 237
Countries citing papers authored by Dante Romagnoli
This map shows the geographic impact of Dante Romagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dante Romagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dante Romagnoli more than expected).
Fields of papers citing papers by Dante Romagnoli
This network shows the impact of papers produced by Dante Romagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dante Romagnoli. The network helps show where Dante Romagnoli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dante Romagnoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 71 | |
| 5 | 2017 | 36 | |
| 6 | 2017 | 109 | |
| 7 | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Riskbreakdown → | 2017 | 404 |
| 8 | 2016 | 63 | |
| 9 | 2016 | 6 | |
| 10 | 2016 | 92 | |
| 11 | 2016 | 125 | |
| 12 | 2015 | 4 | |
| 13 | 2015 | 97 | |
| 14 | 2015 | 10 | |
| 15 | Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysisbreakdown → | 2015 | 539 |
| 16 | 2014 | 7 | |
| 17 | 2013 | 22 | |
| 18 | 2012 | 17 | |
| 19 | 2012 | 157 | |
| 20 | Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study. | 1988 | 2 |
About Dante Romagnoli
Dante Romagnoli is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (6 papers), Diet, Metabolism, and Disease (5 papers), Hepatitis C virus research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Diseases and Immunity (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Hepatology (616 citations), Endocrinology, Diabetes and Metabolism (820 citations) and Epidemiology (1.6k citations). Dante Romagnoli has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Amedeo Lonardo, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Giovanni Targher, Alessandra Marrazzo, Giovanni Guaraldi, Stefano Zona, Alberto Roverato and Paola Loria. Their work appears in journals such as Advances in Therapy, World Journal of Gastroenterology, Digestive and Liver Disease, Liver International and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.